U.S. markets closed

Bicycle Therapeutics plc (BCYC)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
26.80-0.34 (-1.25%)
At close: 4:00PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Fast Stochastic

Fast Stochastic

Previous Close27.14
Open27.14
Bid25.73 x 1300
Ask28.40 x 800
Day's Range25.71 - 27.77
52 Week Range10.26 - 33.00
Volume198,851
Avg. Volume92,874
Market Cap570.969M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-4.99
Earnings DateNov 05, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est34.88
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Business Wire

    Bicycle Therapeutics Announces Pipeline Progress Update

    Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced progress updates for its wholly owned, next-generation Bicycle Toxin Conjugates (BTCs) targeting oncological indications, as well as its novel, fully synthetic Bicycle tumor-targeted immune cell agonists (TICAs™).

  • Is Bicycle Therapeutics (NASDAQ:BCYC) Using Debt In A Risky Way?
    Simply Wall St.

    Is Bicycle Therapeutics (NASDAQ:BCYC) Using Debt In A Risky Way?

    Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...

  • Is BCYC A Good Stock To Buy Now?
    Insider Monkey

    Is BCYC A Good Stock To Buy Now?

    In this article we will analyze whether Bicycle Therapeutics plc (NASDAQ:BCYC) is a good investment right now by following the lead of some of the best investors in the world and piggybacking their ideas. There’s no better way to get these firms’ immense resources and analytical capabilities working for us than to follow their lead […]